{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:34:56Z","timestamp":1774406096301,"version":"3.50.1"},"reference-count":80,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00232."],"award-info":[{"award-number":["22-15-00232."]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fetal arrhythmia develops in 0.1\u20135% of pregnancies and may cause fetal heart failure and fetal hydrops, thus increasing fetal, neonatal, and infant mortality. The timely initiation of transplacental antiarrhythmic therapy (ART) promotes the conversion of fetal tachycardia to sinus rhythm and the regression of the concomitant non-immune fetal hydrops. The optimal treatment regimen search for the fetus with tachyarrhythmia is still of high value. Polymorphisms of these genes determines the individual features of the drug pharmacokinetics. The aim of this study was to study the pharmacokinetics of transplacental anti-arrhythmic drugs in the fetal therapy of arrhythmias using HPLC-MS\/MS, as well as to assess the effect of the multidrug-resistance gene ABCB1 3435C &gt; T polymorphism on the efficacy and maternal\/fetal complications of digoxin treatment. The predisposition to a decrease in the bioavailability of the digoxin in patients with a homozygous variant of the CC polymorphism showed a probable association with the development of ART side effects. A pronounced decrease in heart rate in women with the 3435TT allele of the ABCB1 gene was found. The homozygous TT variant in the fetus showed a probable association with an earlier response to ART and rhythm disruptions on the digoxin dosage reduction. high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS\/MS) methods for digoxin and sotalol therapeutic drug monitoring in blood plasma, amniotic fluid, and urine were developed. The digoxin and sotalol concentrations were determined in the plasma blood, urine, and amniotic fluid of 30 pregnant women at four time points (from the beginning of the transplacental antiarrhythmic therapy to delivery) and the plasma cord blood of 30 newborns. A high degree of correlation between the level of digoxin and sotalol in maternal and cord blood was found. The ratio of digoxin and sotalol in cord blood to maternal blood was 0.35 (0.27 and 0.46) and 1.0 (0.97 and 1.07), accordingly. The digoxin concentration in the blood of the fetus at the moment of the first rhythm recovery episode, 0.58 (0.46, 0.8) ng\/mL, was below the therapeutic interval. This confirms the almost complete transplacental transfer of sotalol and the significant limitation in the case of digoxin. Previously, ABCB1\/P-glycoprotein had been shown to limit fetal exposure to drugs. Further studies (including multicenter ones) to clarify the genetic features of the transplacental pharmacokinetics of antiarrhythmic drugs are needed.<\/jats:p>","DOI":"10.3390\/ijms24031848","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T01:57:57Z","timestamp":1674007077000},"page":"1848","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS\/MS"],"prefix":"10.3390","volume":"24","author":[{"given":"Natalia","family":"Starodubtseva","sequence":"first","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"},{"name":"Moscow Institute of Physics and Technology, 141700 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Kindysheva","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyona","family":"Potapova","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenii","family":"Kukaev","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"},{"name":"V.L. Talrose Institute for Energy Problems of Chemical Physics, Russia Academy of Sciences, 119991 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfiya","family":"Khodzhaeva","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Bockeria","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaliy","family":"Chagovets","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Frankevich","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"},{"name":"Laboratory of Translational Medicine, Siberian State Medical University, 634050 Tomsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennady","family":"Sukhikh","sequence":"additional","affiliation":[{"name":"National Medical Research Center for Obstetrics Gynecology and Perinatology Named after Academician V.I., Kulakov of the Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1055\/s-0034-1372430","article-title":"Diagnosis and Treatment of Fetal Arrhythmia","volume":"31","author":"Strasburger","year":"2014","journal-title":"Am. J. Perinatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e007164","DOI":"10.1161\/JAHA.117.007164","article-title":"First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis","volume":"6","author":"Alsaied","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hjc.2018.12.003","article-title":"Fetal arrhythmias: Surveillance and management","volume":"60","author":"Yuan","year":"2019","journal-title":"Hell. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/jce.14406","article-title":"Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience","volume":"31","author":"Alexander","year":"2020","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MOP.0b013e32830f93ec","article-title":"Overview of fetal tachycardia: Outcomes in a 30-year single-institution experience","volume":"20","author":"Srinivasan","year":"2008","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/uog.12390","article-title":"Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up","volume":"42","author":"Oudijk","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.amjcard.2012.01.388","article-title":"Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias","volume":"109","author":"Shah","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/uog.12576","article-title":"Re: Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. L. B. van der Heijden, M. A. Oudijk, G. Manten, H. ter Heide, L. Pistorius and M. W. Freund. Ultrasound Obstet Gynecol. 2013, 42, 285\u2013293","volume":"42","author":"Strasburger","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.hrthm.2016.01.029","article-title":"High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia","volume":"13","author":"Strizek","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/heart.89.10.1211","article-title":"Management of fetal tachyarrhythmia based on superior vena cava\/aorta Doppler flow recordings","volume":"89","author":"Fouron","year":"2003","journal-title":"Heart"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13052-020-0785-9","article-title":"Fetal arrhythmias: Prenatal evaluation and intrauterine therapeutics","volume":"46","author":"Yuan","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17512433.2017.1344096","article-title":"Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia","volume":"10","author":"Suarez","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/pd.5144","article-title":"Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis","volume":"37","author":"Hill","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1469-0705.1991.01030162.x","article-title":"Fetal tachyarrhythmias: Transplacental and direct treatment of the fetus-a report of 60 cases","volume":"1","author":"Hansmann","year":"1991","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","first-page":"1137","article-title":"Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene","volume":"297","author":"Tanabe","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","article-title":"Expression of the Multidrug Resistance P-Glycoprotein, (ABCB1 glycoprotein) in the Human Placenta Decreases with Advancing Gestation","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17425255.2018.1499726","article-title":"An update on expression and function of P-gp\/ABCB1 and BCRP\/ABCG2 in the placenta and fetus","volume":"14","author":"Han","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/gut.52.5.759","article-title":"Multidrug resistance 1 gene (P-glycoprotein 170): An important determinant in gastrointestinal disease?","volume":"52","author":"Ho","year":"2003","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00228-003-0606-2","article-title":"Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population","volume":"59","author":"Gaikovitch","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_22","first-page":"93","article-title":"A Comparison of CYP2C9, CYP2C19, CYP2D6, frequency in Russian and Nanai populations. Pharmgenomics","volume":"10","author":"Sychev","year":"2017","journal-title":"Pers. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejogrb.2020.11.055","article-title":"Maternal effects induced by oral digoxin during treatment of fetal tachyarrhythmia: Case series and literature review","volume":"256","author":"Chimenea","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ejhf.584","article-title":"Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial","volume":"18","author":"Adams","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jacc.2019.06.024","article-title":"Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial","volume":"74","author":"Miyoshi","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1203\/00006450-198601000-00007","article-title":"Digoxin-and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates","volume":"20","author":"Ebara","year":"1986","journal-title":"Pediatr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0735-1097(03)00779-4","article-title":"Treatment of fetal tachycardia with sotalol: Transplacental pharmacokinetics and pharmacodynamics","volume":"42","author":"Oudijk","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109813","DOI":"10.1016\/j.biopha.2020.109813","article-title":"Digoxin as a glycosylated steroid-like therapeutic drug: Recent advances in the clinical pharmacology and bioassays of pharmaceutical compounds","volume":"123","author":"Hasanzadeh","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clinbiochem.2018.10.006","article-title":"Characterization of bilirubin interference in three commonly used digoxin assays","volume":"63","author":"Simonson","year":"2019","journal-title":"Clin. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00139709-200625040-00007","article-title":"Therapeutic drug monitoring of digoxin: Impact of endogenous and exogenous digoxin-like immunoreactive substances","volume":"25","author":"Dasgupta","year":"2006","journal-title":"Toxicol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/FTD.0b013e31816b918f","article-title":"Herbal supplements and therapeutic drug monitoring: Focus on digoxin immunoassays and interactions with St. John\u2019s wort","volume":"30","author":"Dasgupta","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1309\/34BJECP7UK6FH13V","article-title":"Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs","volume":"119","author":"Dasgupta","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4155\/bio.09.14","article-title":"Digoxin\u2014A therapeutic agent and mechanistic probe: Review of liquid chromatographic mass spectrometric methods and recent nuances in the clinical pharmacology attributes of digoxin","volume":"1","author":"Srinivas","year":"2009","journal-title":"Bioanalysis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1016\/j.chroma.2010.04.060","article-title":"Simultaneous determination of various cardiac glycosides by liquid chromatography\u2013hybrid mass spectrometry for the purity assessment of the therapeutic monitored drug digoxin","volume":"1217","author":"Josephs","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1248\/bpb.30.1653","article-title":"Determination of digoxin in human serum using stable isotope dilution liquid chromatography\/electrospray ionization-tandem mass spectrometry","volume":"30","author":"Mitamura","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jchromb.2008.05.026","article-title":"Validation and application of a 96-well format solid-phase extraction and liquid chromatography\u2013tandem mass spectrometry method for the quantitation of digoxin in human plasma","volume":"869","author":"Hashimoto","year":"2008","journal-title":"Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinbiochem.2009.09.025","article-title":"Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS\/MS method","volume":"43","author":"Li","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-4347(96)00462-8","article-title":"High-performance liquid chromatography\u2013ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma","volume":"692","author":"Tracqui","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/elps.202100290","article-title":"Development of a new ultra-high-performance liquid chromatography\u2013tandem mass spectrometry method for the determination of digoxin and digitoxin in plasma: Comparison with a clinical immunoassay","volume":"43","author":"Ballotari","year":"2022","journal-title":"Electrophoresis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10995-006-0102-2","article-title":"Ensuring the Safe and Effective use of Medications During Pregnancy: Planning and Prevention Through Preconception Care","volume":"10","author":"Cragan","year":"2006","journal-title":"Matern. Child Health J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"Vahakangas","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1203\/PDR.0b013e3180a02e50","article-title":"Antiepileptic medication during pregnancy: Does fetal genotype affect outcome?","volume":"62","year":"2007","journal-title":"Pediatr. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"1998","journal-title":"Reprod. Toxicol."},{"key":"ref_45","first-page":"57","article-title":"Determination of Digoxin in the Blood of Pregnant Women, Fetuses and Neonates before and during Anti-arrhythmic Therapy, Using Four Immunochemical Methods","volume":"29","author":"Lankas","year":"1991","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.99.4.552","article-title":"Inhibition of P-Glycoprotein-mediated Drug Transport. Unifying mechanism to Explain the interaction Between Digoxin and Quinidine","volume":"99","author":"Fromm","year":"1999","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of Therapeutic Drug Monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jogoh.2017.11.013","article-title":"Maternal complications induced by digoxin treatment of fetal tachycardia: A retrospective series of 18 cases","volume":"47","author":"Moatassim","year":"2018","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00228-003-0567-5","article-title":"Digoxin pharmacokinetics and MDR1 genetic polymorphisms","volume":"58","author":"Verstuyft","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/IJGM.S218393","article-title":"Prediction of serum digoxin concentration using estimated glomerular filtration rate in Thai population","volume":"12","author":"Doungngern","year":"2019","journal-title":"Int. J. Gen. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bochud, M., Eap, C.B., Maillard, M., Johnson, T., Vollenweider, P., Bovet, P., Elston, R.C., Bergmann, S., Beckmann, J.S., and Waterworth, D.M. (2008). Association of ABCB1genetic variants with renal function in Africans and in Caucasians. BMC Med. Genom., 1.","DOI":"10.1186\/1755-8794-1-21"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","article-title":"Diagnosis and treatment of fetal cardiac disease: A scientific statement from the american heart association","volume":"129","author":"Donofrio","year":"2014","journal-title":"Circulation"},{"key":"ref_53","first-page":"28","article-title":"Fetal dysrhythmias","volume":"Volume 58","author":"Carvalho","year":"2019","journal-title":"Best Practice and Research: Clinical Obstetrics and Gynaecology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"935455","DOI":"10.3389\/fphar.2022.935455","article-title":"Efficacy and Safety of Various First-Line Therapeutic Strategies for Fetal Tachycardias: A Network Meta-Analysis and Systematic Review","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clp.2015.11.007","article-title":"Fetal and Neonatal Arrhythmias","volume":"43","author":"Jaeggi","year":"2016","journal-title":"Clin. Perinatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/apc.APC_134_17","article-title":"Fetal cardiac arrhythmias: Current evidence","volume":"11","author":"Rocha","year":"2018","journal-title":"Ann. Pediatr. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.111.026120","article-title":"Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: Results of a nonrandomized multicenter study","volume":"124","author":"Jaeggi","year":"2011","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcv.2014.08.028","article-title":"Case of a healthy infant born following antenatal enterovirus myocarditis and hydrops","volume":"61","author":"Bonnin","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0031-1277102","article-title":"Reversible Atrioventricular Block and Junctional Ectopic Tachycardia in Coxsackievirus B3-Induced Fetal\u2013Neonatal Myocarditis without Left Ventricular Dysfunction","volume":"1","author":"Takahashi","year":"2011","journal-title":"Am. J. Perinatol. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002460010214","article-title":"Ventricular aneurysm complicating neonatal Coxsackie B4 myocarditis","volume":"22","author":"Chan","year":"2001","journal-title":"Pediatr. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00431-008-0688-z","article-title":"Atypical manifestations of congenital parvovirus B19 infection","volume":"167","author":"Savarese","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"ref_62","first-page":"2","article-title":"Perinatal management of fetal supraventricular tachycardia complicated by maternal pertussis","volume":"2015","author":"DeJong","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21508\/1027-4065-2019-64-4-6-10","article-title":"Perinatal cardiology: The present and the future. Part II: Cardiac arrhythmias and conduction","volume":"64","author":"Bockerija","year":"2019","journal-title":"Ross. Vestn. Perinatol. Pediatr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1447-0756.2009.01080.x","article-title":"Fetal arrhythmia: Prenatal diagnosis and perinatal management","volume":"35","author":"Maeno","year":"2009","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_65","first-page":"361","article-title":"Pharmacology for the fetus and the newborn","volume":"151","year":"2015","journal-title":"Gac. Med. Mex."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/bmc.988","article-title":"Sensitive and specific LC-MS assay for quantification of digoxin in human plasma and urine","volume":"22","author":"Kirby","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4155\/bio-2018-0075","article-title":"Sensitive and robust LC-MS\/MS analysis of digoxin in human plasma through optimization of in-source adduct formation","volume":"10","author":"Keane","year":"2018","journal-title":"Bioanalysis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1021\/ac503187z","article-title":"Rapid quantification of digitoxin and its metabolites using differential ion mobility spectrometry-tandem mass spectrometry","volume":"87","author":"Bylda","year":"2015","journal-title":"Anal. Chem."},{"key":"ref_69","first-page":"138","article-title":"A sensitive method for digoxin determination using formate-adduct ion based on the effect of ionization enhancement in liquid chromatograph-mass spectrometer","volume":"978\u2013979","author":"Li","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/10826070600757821","article-title":"Rapid Quantitation of Digoxin in Human Plasma and Urine Using Isotope Dilution Liquid Chromatography-Tandem Mass Spectrometry","volume":"29","author":"Salvador","year":"2006","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2014.10.028","article-title":"Screening approach by ultra-high performance liquid chromatography\u2013tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology","volume":"975","author":"Carlier","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/jat\/33.7.372","article-title":"Determination of digoxin and digitoxin in whole blood","volume":"33","author":"Johansen","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.1980.tb04618.x","article-title":"Sotalol As a Hypotensive Agent in Pregnancy","volume":"87","author":"Murnaghan","year":"1980","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00008571-200405000-00006","article-title":"Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1)","volume":"14","author":"Hitzl","year":"2004","journal-title":"Pharmacogenetics"},{"key":"ref_75","unstructured":"Le, J. (2022). Overview of Pharmacokinetics, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-Glycoprotein Transport System and Cardiovascular Drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/archdischild-2013-305309","article-title":"Therapeutic drug monitoring in neonates","volume":"101","author":"Pauwels","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1295e8","DOI":"10.1016\/0959-8049(95)00130-B","article-title":"Multidrug resistance and the role of P-glycoprotein knockout mice","volume":"31","author":"Schinkel","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"ref_79","unstructured":"(2022, July 25). M10 Bioanalytical Method Validation and Study Sample Analysis; International Council for Harmonisation; Guidance for Industry; Availability\/\/ Food and Drug Administration, HHS, Current Step 5, Version 2022. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1586\/14737159.1.1.92","article-title":"Mutation Detection Using Fluorescent Hybridization Probes and Melting Curve Analysis","volume":"1","author":"Lyon","year":"2001","journal-title":"Exp. Rev. Mol. Diagn."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/1848\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:08:28Z","timestamp":1760119708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/1848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24031848"],"URL":"https:\/\/doi.org\/10.3390\/ijms24031848","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}